MedPath

The use of prophylactic antibiotics for percutaneous K-wires in orthopaedic surgery - Antibiotic usage with percutaneous K-wires

Phase 1
Conditions
INfection following k-wire insertion
Registration Number
EUCTR2009-011342-26-GB
Lead Sponsor
Great Western Hospital, Swindon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

All patients requiring percutaneous K-wires during their orthopaedic surgery will be invited to participate. Patients who are unable to understand the patient information leaflet and provide a valid consent will be excluded.
Are the trial subjects under 18?
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients will also be excluded if there is a proven high risk of infection e.g. patients with an open, contaminated wounds, poor local skin condition, immunosuppresed patients, and other co-morbidities which may increase the possibility of an infection.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.;Secondary Objective: Do we need to give antibiotics to patients who need percutaneous K-wires?;Primary end point(s): To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath